G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan · Delayed Price · Currency is TWD 28.00
0.00 (0.00%)
Oct 8, 2026, 1:17 PM CST
G&E Herbal Biotechnology Market Cap
G&E Herbal Biotechnology has a market cap or net worth of 1.93 billion as of October 9, 2026. It is the 29,065th most valuable company in the world and the 1,698th biggest in Taiwan. Its market cap has decreased by 34.29% in one year.
Market Cap
1.93B
Enterprise Value
1.50B
Revenue
215.61M
Global Rank
Country Rank
#1,698 Taiwan
PE Ratio
22.41
ChartMarket Cap Chart
Since April 28, 2008, G&E Herbal Biotechnology's market cap has decreased from 2.62B to 1.93B, a decrease of -26.43%. That is a compound annual growth rate of -1.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.93B | -29.51% |
| Dec 31, 2025 | 2.73B | -18.14% |
| Dec 31, 2024 | 3.34B | -2.92% |
| Dec 29, 2023 | 3.44B | 15.73% |
| Dec 30, 2022 | 2.97B | 90.71% |
| Dec 30, 2021 | 1.56B | -19.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeXun Biosciences | 2.29B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.29B |
| Taiwan Bio Therapeutics | 2.28B |
| Syngen Biotech | 2.19B |
| Anti-Microbial Savior BioteQ | 2.01B |
| U-Neuron Biomedical | 1.75B |
| Synbio Tech | 1.73B |
| TaiRx | 1.69B |